EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities

Sources:
– Text: aicep Portugal Global
– Photo: teksomolika

EXMceuticals Inc., (the “Company” or “EXM”), an emerging bio-sciences company specializing in the production of unique cannabinoid formulations, is pleased to announce its success in securing COVID-19 R&D-focused grant from the European Union and the Portuguese Government, detailing a landmark event for the Company.

A Consortium led by EXMceuticals Portugal Lda, operating under the Project name “BioBlockCOVID” and consisting of EXMceuticals Portugal Lda, Cosmetek Lda, and the Universidade de Coimbra has been awarded EUR 302.000 by the European Regional Development Fund and the Portuguese Government to study further and develop disinfectants to combat SARScoV-2, the virus that causes COVID-19.

More information, click here

Leave a Reply

%d bloggers like this: